Select a medication above to begin.
Adzenys XR-ODT
amphetamine
Black Box Warnings .
Abuse, Misuse, and Addiction
CNS stimulants have high potential for abuse and misuse, can lead to substance use disorder, incl. addiction; misuse and abuse can result in overdose and death, risk incr. w/ higher doses or unapproved admin. methods; assess risk for abuse, misuse, and addiction before prescribing and throughout tx; educate pts and families about risks and proper drug storage and disposal; monitor frequently for s/sx of abuse, misuse, and addiction during tx
Adult Dosing .
Dosage forms: ER ODT: 3.1 mg, 6.3 mg, 9.4 mg, 12.5 mg, 15.7 mg, 18.8 mg
Special Note
- [formulation clarification]
- Info: amphetamine ER products not interchangeable; do not substitute on a mg to mg basis; retitrate if switching between products
ADHD
- [12.5 mg PO qam]
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: ER ODT: 3.1 mg, 6.3 mg, 9.4 mg, 12.5 mg, 15.7 mg, 18.8 mg
Special Note
- [formulation clarification]
- Info: amphetamine ER products not interchangeable; do not substitute on a mg to mg basis; retitrate if switching between products
ADHD
- [6-12 yo]
- Dose: 6.3-18.8 mg PO qam; Start: 6.3 mg PO qam, incr. by 3.1-6.3 mg/day qwk; Max: 18.8 mg/day
- [13-17 yo]
- Dose: 6.3-12.5 mg PO qam; Start: 6.3 mg PO qam, incr. by 3.1-6.3 mg/day qwk; Max: 12.5 mg/day
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]